Company Data
Kazia Therapeutics Limited
Ticker
KZIA
Current Price
$3.8 0.53%
Market Cap
$5.2M
Price Target
Refer to Report
Volume
13.9K
52wk Range
$2.86 - $395
Overview
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.